EPIX Pharmaceuticals to Present at the JPMorgan 25th Annual
MSN MoneyCentral - chronic obstructive pulmonary disease, PRX-03140 which is in a Phase 2a clinical trial in Alzheimer's disease, PRX-00023 which is being developed to treat major depression, and PRX-07034, which is in Phase 1 clinical development for the treatment
Source: news.moneycentral.msn.com
Click here for more information about alcohol depression alcohol depression
<< Home